news
news

Cancer Drug Price Cuts Limited: 25% Packs Unaffected

The National Pharmaceutical Pricing Authority (NPPA) has released a revised price list for cancer drugs, but nearly 25% of the drug packs will not see any reduction in their maximum retail price (MRP). While the overall average price cut across 643 packs is 38.22%, several high-cost patented medicines remain unchanged. This has raised concerns among patient advocates about the effectiveness of the trade-margin cap in providing relief. The new prices are set to take effect on November 9. For detailed information, refer to the official publication.

Read the original article

© Neo Logistics. All Rights Reserved. Powered by ImpressAds